Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease (Q28610102)

From Wikidata

Jump to navigation Jump to search

scientific journal article

Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease

Language	Label	Description	Also known as
English	Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease	scientific journal article	Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease

Statements

scholarly article

1 reference

PubMed publication ID

3 February 2017

Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease (English)

1 reference

PubMed publication ID

3 February 2017

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

O. M. El-Agnaf

1

1 reference

PubMed publication ID

3 February 2017

R. Jakes

2

1 reference

PubMed publication ID

3 February 2017

M. D. Curran

3

1 reference

PubMed publication ID

3 February 2017

A. Wallace

4

1 reference

PubMed publication ID

3 February 2017

language of work or name

0 references

publication date

27 November 1998

1 reference

PubMed publication ID

3 February 2017

1 reference

PubMed publication ID

3 February 2017

440

1 reference

PubMed publication ID

3 February 2017

1-2

1 reference

PubMed publication ID

3 February 2017

67–70

1 reference

PubMed publication ID

3 February 2017

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Chaperoning brain diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

The influence of the central region containing residues 19-25 on the aggregation properties and secondary structure of Alzheimer's beta-amyloid peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

A kinetic model for amyloid formation in the prion diseases: importance of seeding

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Identification of two distinct synucleins from human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Alpha synuclein in neurodegenerative disorders: murderer or accomplice?

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Comparative analysis of human and Dutch-type Alzheimer beta-amyloid peptides by infrared spectroscopy and circular dichroism

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Prion protein peptides induce alpha-helix to beta-sheet conformational transitions

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Conformational transitions in peptides containing two putative alpha-helices of the prion protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Neurotoxicity of a prion protein fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

α-synuclein—a link between Parkinson and Alzheimer diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Gene discovery offers tentative clues to Parkinson's.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Aggregation and metal-binding properties of mutant forms of the amyloid A beta peptide of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

21 January 2018

Pathology and biology of the Lewy body

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901419-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0014-5793(98)01419-7

0 references

PubMed publication ID

1 reference

PubMed publication ID

3 February 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28610102&oldid=2030853364"